Discovery Laboratories, Inc. Stock Nasdaq
Equities
US2546684034
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Apr. 16 | Windtree Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Apr. 11 | North American Morning Briefing : Stock Futures -2- | DJ |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 2.23M |
---|---|---|---|---|---|
Net income 2024 * | -21M | Net income 2025 * | -29M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.25
x | P/E ratio 2025 * |
-0.37
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.99% |
Latest transcript on Discovery Laboratories, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Craig Fraser
CEO | Chief Executive Officer | 59 | 16-01-31 |
Eric Curtis
COO | Chief Operating Officer | 56 | 20-03-08 |
George Cox
CTO | Chief Tech/Sci/R&D Officer | 73 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Scott
BRD | Director/Board Member | 70 | 21-02-02 |
Mark Strobeck
BRD | Director/Board Member | 53 | 23-06-21 |
Leslie Williams
BRD | Director/Board Member | 64 | 21-02-02 |
1st Jan change | Capi. | |
---|---|---|
+41.79% | 54.04B | |
+46.79% | 41.96B | |
-0.56% | 41.92B | |
-7.20% | 28.35B | |
+12.59% | 26.35B | |
-21.51% | 19B | |
+6.92% | 13B | |
+29.60% | 12.28B | |
+24.91% | 12.19B |